John Furey's Net Worth
$1.21 Million
Who is John Furey?
John Furey has an estimated net worth of $1.21 Million. This is based on reported shares across multiple companies, which include Adaptimmune Therapeutics PLC, Spark Therapeutics, Inc., and Vaxcyte, Inc..
SEC CIK
John Furey's CIK is 0001691218
Past Insider Trading and Trends
2018 was John Furey's most active year for acquiring shares with 6 total transactions. John Furey's most active month to acquire stocks was the month of June. 2018 was John Furey's most active year for disposing of shares, totalling 8 transactions. John Furey's most active month to dispose stocks was the month of March. 2018 saw John Furey paying a total of $1,989,600.00 for 92,500 shares, this is the most they've acquired in one year. In 2018 John Furey cashed out on 80,000 shares for a total of $3,200,530.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptimmune Therapeutics PLC (ADAP) Snapshot price: $1.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Spark Therapeutics, Inc. No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$66.12 | -$220,245.48 |
0
|
Scheduled
|
Apr 20
| ||
Form 4
|
—
|
0
|
$66.13 | -$435,284.52 |
0
|
Scheduled
|
Apr 17 - Apr 18
| ||
Form 4
|
—
|
0
|
$63.63 | -$555,400.00 |
0
|
Apr 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
$59.91 | $488.70 |
0
|
Dec 8 - Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vaxcyte, Inc. (PCVX) Snapshot price: $111.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |